Chebli Mrad

450 total citations
8 papers, 104 citations indexed

About

Chebli Mrad is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Chebli Mrad has authored 8 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Surgery. Recurrent topics in Chebli Mrad's work include Palliative Care and End-of-Life Issues (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer therapeutics and mechanisms (1 paper). Chebli Mrad is often cited by papers focused on Palliative Care and End-of-Life Issues (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer therapeutics and mechanisms (1 paper). Chebli Mrad collaborates with scholars based in United States. Chebli Mrad's co-authors include Isabella Bergagnini, Joshua K. Sabari, Alexander Drilon, Kathryn C. Arbour, Marwan S. Abougergi, W. Victoria Lai, Alison M. Schram, Fernando C. Santini, Bobby Daly and John R. Saltzman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Chebli Mrad

8 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chebli Mrad United States 5 63 57 34 14 13 8 104
Aiping Zhou China 7 79 1.3× 54 0.9× 35 1.0× 18 1.3× 25 1.9× 28 133
Luca Campedel France 6 42 0.7× 32 0.6× 20 0.6× 17 1.2× 12 0.9× 26 93
L. Belmont France 7 73 1.2× 77 1.4× 37 1.1× 24 1.7× 18 1.4× 19 154
Pei Jye Voon Malaysia 7 127 2.0× 118 2.1× 51 1.5× 20 1.4× 24 1.8× 28 199
Nicola Trim United Kingdom 5 86 1.4× 83 1.5× 39 1.1× 21 1.5× 13 1.0× 8 151
JoAl Mayor United States 7 41 0.7× 76 1.3× 31 0.9× 6 0.4× 12 0.9× 17 122
Martín Lázaro-Quintela Spain 9 84 1.3× 89 1.6× 42 1.2× 22 1.6× 30 2.3× 20 170
John McGrane United Kingdom 7 50 0.8× 75 1.3× 25 0.7× 19 1.4× 28 2.2× 29 139
Cheng Tzu Yen Brazil 4 61 1.0× 39 0.7× 36 1.1× 13 0.9× 21 1.6× 5 101
Oana Cojocarasu France 6 45 0.7× 94 1.6× 25 0.7× 12 0.9× 12 0.9× 15 135

Countries citing papers authored by Chebli Mrad

Since Specialization
Citations

This map shows the geographic impact of Chebli Mrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chebli Mrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chebli Mrad more than expected).

Fields of papers citing papers by Chebli Mrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chebli Mrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chebli Mrad. The network helps show where Chebli Mrad may publish in the future.

Co-authorship network of co-authors of Chebli Mrad

This figure shows the co-authorship network connecting the top 25 collaborators of Chebli Mrad. A scholar is included among the top collaborators of Chebli Mrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chebli Mrad. Chebli Mrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Singh, Abhay, Megan M. Herr, Elizabeth A. Griffiths, et al.. (2021). Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States. Scientific Reports. 11(1). 23284–23284. 4 indexed citations
2.
Mrad, Chebli, Marwan S. Abougergi, & Bobby Daly. (2018). One Step Forward, Two Steps Back: Trends in Aggressive Inpatient Care at the End of Life for Patients With Stage IV Lung Cancer. Journal of Oncology Practice. 14(12). e746–e757. 8 indexed citations
3.
Mrad, Chebli, et al.. (2018). Trends in aggressive inpatient care at the end-of-life for stage IV lung cancer patients.. Journal of Clinical Oncology. 36(30_suppl). 26–26. 1 indexed citations
5.
Sabari, Joshua K., Fernando C. Santini, Alison M. Schram, et al.. (2017). The activity, safety, and evolving role of brigatinib in patients with <em>ALK</em>-rearranged non-small cell lung cancers. OncoTargets and Therapy. Volume 10. 1983–1992. 46 indexed citations
6.
7.
Sabari, Joshua K., Joseph Montecalvo, Jordan Dienstag, et al.. (2017). PD-L1 expression and response to immunotherapy in patients with MET exon 14-altered non-small cell lung cancers (NSCLC).. Journal of Clinical Oncology. 35(15_suppl). 8512–8512. 29 indexed citations
8.
Abougergi, Marwan S., et al.. (2017). The Impact of Obesity on Mortality and Other Outcomes in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage in the United States. Journal of Clinical Gastroenterology. 53(2). 114–119. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026